Global Cardiac Arrest Treatment Market (2021 to 2026) – By Treatment, Distribution Channel and Geography

0

Dublin, Jan. 27, 2022 (GLOBE NEWSWIRE) — The “Global Cardiac Arrest Treatment Market (2021-2026) by Treatment, Distribution Channel and Geography, Competitive Analysis and Impact of Covid-19 with Ansoff Analysis” report has been added to from ResearchAndMarkets.com offer.

Global Cardiac Arrest Treatment Market is estimated to be valued at USD 17.63 Billion in 2021 and is projected to reach USD 27.39 Billion by 2026, growing at a CAGR of 9.21%.

Market dynamics

The major factor increasing the global cardiac arrest treatment market is an increase in cardiovascular disorders (CVD). The increasingly sedentary lifestyle, high consumption of alcohol and tobacco, and the increase in the geriatric population lead to an increase in cardiovascular disease. Additionally, the growing awareness among the population about cardiac resynchronization therapy devices is accelerating the growth of the market. However, frequent product calls and high processing cost are expected to hamper the market during the forecast period.

Huge investments in research and development associated with cardiac arrest treatment are expected to create new opportunities for the market over the forecast period.

Market segmentation

The global cardiac arrest treatment market is segmented on the basis of treatment, distribution channel and geography.

By treatment, the market is classified as drugs and medical devices. Among the two, the medical device segment is expected to hold the highest market share during the forecast period.

By distribution channel, the market is categorized as hospitals, retail pharmacies, online pharmacies, and others. Among all, Hospitals segment is estimated to hold the highest market share during the forecast period.

Based on geography, North America is expected to dominate the market.

Company Profiles

Some of the companies covered in this report are Medico SpA, Medtronic plc, Novartis AG, Neurescue, Nihon Kohden Corporation, Pfizer, etc.

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and assess the position of companies based on their industry position score and market performance score. The tool uses various factors to classify players into four categories. Some of these factors considered for analysis are financial performance over the past 3 years, growth strategies, innovation score, new product launches, investments, market share growth, etc

Why buy this report?

  • The report offers a comprehensive assessment of the global Cardiac Arrest Treatment market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and market size projections. Projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The main research is done through interviews, surveys and observations of renowned personnel in the industry.
  • The report includes in-depth market analysis using Porter’s 5 forces model and Ansoff’s matrix. Additionally, the impact of Covid-19 on the market is also presented in the report.
  • The report also includes the regulatory scenario in the industry, which will help you to make an informed decision. The report discusses the major regulatory bodies and major rules and regulations imposed on this industry across various geographies.
  • The report also contains competitive analysis using Positioning Quadrants, the analyst’s proprietary competitive positioning tool.

Main topics covered:

1 Description of the report

2 Research methodology

3 Executive summary
3.1 Presentation
3.2 Market Size and Segmentation
3.3 Market Outlook

4 market influencers
4.1 Drivers
4.1.1 Increasing burden of cardiovascular disease
4.1.2 Increase in the geriatric population
4.1.3 Growing Awareness of Generic Drugs and Minimally Invasive Procedures
4.1.4 Favorable refund policies
4.2 Constraints
4.2.1 Expensive Treatment and Device Replacement Cost
4.3 Opportunities
4.3.1 Technological progress
4.3.2 Rising healthcare spending in emerging countries
4.4 Challenges
4.4.1 Lack of qualified professionals
4.4.2 Product recalls
4.5 Trends

5 Market Analysis
5.1 Regulatory scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff matrix analysis

6 Global Cardiac Arrest Treatment Market, By Treatment
6.1 Presentation
6.2 Medicines
6.2.1 Vasopressors
6.2.2 Antiarrhythmic drugs
6.2.3 Anticholinergic drugs
6.2.4 Corticosteroids
6.2.5 Fibrinolytic drugs
6.2.6 Beta-blockers
6.2.7 Others
6.3 Medical devices
6.3.1 Defibrillators
6.3.1.1 Implantable cardioverter defibrillators
6.3.1.2 External defibrillators
6.3.2 Pacemakers
6.3.2.1 Implantable pacemakers
6.3.2.2 External pacemaker
6.3.3 Others

7 Global Cardiac Arrest Treatment Market, by Distribution Channel
7.1 Presentation
7.2 Hospitals
7.3 Retail pharmacies
7.4 Online pharmacies
7.5 Others

8 Global Cardiac Arrest Treatment Market, By Geography

9 Competitive landscape
9.1 Competitive Quadrant
9.2 Market Share Analysis
9.3 Strategic Initiatives
9.3.1 Mergers and Acquisitions and Investments
9.3.2 Partnerships and collaborations
9.3.3 Product developments and improvements

10 company profiles
10.1 Abbott Laboratories
10.2 Amgen Inc.
10.3 Allergan
10.4 Bayer AG
10.5 Biotronik SE & Co. KG
10.6 Boston Scientific Corporation
10.7 Bristol Myers Squibb Company
10.8 Fukuda Denshi Co.,Ltd
10.9 Koninklijke Philips NV
10.10 LivaNova PLC
10.11 Lepu Medical
10.12 MicroPort Scientific Corporation
10.13 Medico SpA
10.14 Medtronic plc
10.15 Novartis AG
10.16 Neurecue
10.17 Nihon Kohden Company
10.18 Medical Osypka
10.19 Pfizer Inc.
10.20 Sanofi SA
10.21 Shree Pacetronix Ltd
10.22 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
10.23 Stryker Corporation
10.24 Viatris Inc.
10.25 ZOLL Medical Society

11 Appendix

For more information on this report, visit https://www.researchandmarkets.com/r/3ophno

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

main logo

Share.

Comments are closed.